亞康股份(301085.SZ):慶陽作為公司第一階段算力中心節點建設,將在12月20日前完成首期不低於1000片GPU(不低於2000P算力)的人工智能算力系統建設
格隆匯9月13日丨亞康股份(301085.SZ)於2023年9月13日接受特定對象調研,就“公司對於算力中心後續的規劃?”,公司回覆稱,慶陽作為公司第一階段算力中心節點建設,將在2023年12月20日前完成首期不低於1000片GPU(不低於2000P算力)的人工智能算力系統建設,後續公司也將依據未來市場需求,依託東數西算節點地區,陸續建設多個類似慶陽相同規模的算力中心,形成公司的算力集羣網絡。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.